Reaction

Mycobacterial Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,700 reports · 84 co-occurring drugs

As of the last recalculation, Mycobacterial Infection appears in 1,700 FAERS reports alongside 84 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPIN (PRR 90.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Rifampin	102	90.9	91.6
Rifampicin	48	59.7	60.0
Moxifloxacin	57	51.2	51.4
Amikacin	67	50.0	50.2
Pyrazinamide	33	43.8	44.0
Isoniazid	55	42.9	43.1
Clarithromycin	111	42.3	42.4
Moxifloxacin Hydrochloride	67	42.1	42.2
Itraconazole	33	35.3	35.4
Azithromycin	92	29.5	29.6
Atovaquone	19	29.2	29.3
Azithromycin Monohydrate	92	28.5	28.6
Amphotericin B	27	26.8	26.9
Tacrolimus Ointment 0.1%	230	26.0	26.0
Tacrolimus Extended-Release Capsules	230	25.9	26.0
Mycophenolate Mofetil	245	25.6	25.7
Mycophenolate Mofetil Hydrochloride	245	25.6	25.6
Lamivudine Oral	47	23.4	23.4
Azithromycin Dihydrate	100	22.1	22.2
Tacrolimus	241	21.8	21.8
Lamivudine	53	21.6	21.7
Ritonavir 100 Mg	26	21.6	21.7
Mepolizumab	82	21.2	21.2
Adalimumab-Fkjp	67	18.4	18.4
Adalimumab-Aaty	67	18.0	18.0
Mycophenilic Acid	29	17.4	17.4
Alemtuzumab	27	17.4	17.4
Basiliximab	16	16.8	16.8
Prednisolone	214	16.5	16.5
Prednisolone Oral	214	16.5	16.5
Prednisolone Oral Solution	214	16.5	16.5
Adalimumab-Adaz	67	16.1	16.2
Ritonavir	37	15.8	15.8
Nicotine Polacrilex Mini	19	15.7	15.7
Nicotine Polarilex	19	15.7	15.7
Ciclesonide	17	15.4	15.4
Darunavir	18	14.7	14.7
Rabeprazole	26	14.6	14.6
Valganciclovir Hydrochloride Powder,	14	14.2	14.2
Azathioprine	95	13.9	13.9
Instalax Polyethylene Glycol 3350	14	13.9	13.9
Fludarabine Phosphate	43	13.7	13.7
Polyethylene Glycol 400	14	13.6	13.6
Melphalan	24	13.1	13.1
Valganciclovir	19	12.5	12.5
Valganciclovir Hydrochloride	19	12.5	12.5
Melphalan Hydrochloride	25	12.4	12.4
Mycophenolic Acid	31	12.1	12.1
Pseudoephedrine Hcl	10	11.2	11.2
Efavirenz	10	11.0	11.0
Linezolid	26	10.8	10.9
Pseudoephedrine Hydrochloride	9	10.8	10.8
Voriconazole Injection	18	10.2	10.3
Daspone	8	10.1	10.1
Dapsone Gel, 5%	8	10.1	10.1
Posaconazole Delayed-Release	9	10.1	10.1
Tiotropium Bromide Inhalation Spray	9	9.9	9.9
Dapsone	8	9.2	9.2
Zidovudine	10	9.2	9.2
Cyclosporine	80	9.2	9.2
Anti-Thymocyte Globulin (Rabbit)	6	9.1	9.1
Lumacaftor And Ivacaftor	6	8.6	8.6
Sirolimus	9	8.2	8.2
Nevirapine	6	8.2	8.2
Tiotropium Bromide	86	8.0	8.0
Busulfan	10	7.8	7.8
Thiotepa	6	7.7	7.7
Atazanavir	9	7.7	7.7
Infliximab	128	7.7	7.7
Dornase Alfa	12	7.5	7.5
Voriconazole	18	7.3	7.3
Budesonide And Formoterol Fumarate Dihydrate	56	7.3	7.3
Micafungin Sodium	5	7.2	7.2
Tenofovir Disoproxil Fumarate Tablets	5	7.1	7.1
Botulinum Toxin Type A	7	6.9	6.9
Posaconazole	9	6.8	6.8
Canagliflozin	15	6.2	6.2
Ivacaftor	4	6.2	6.2
Tobramycin	12	6.1	6.1
Nicotine Polacrilex	19	6.1	6.1
Nicotine	20	6.1	6.1
Prasugrel Hydrochloride	5	6.0	6.0
Elexacaftor, Tezacaftor, And Ivacaftor	6	5.9	5.9
Abatacept	49	4.4	4.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.